CoChat

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

Open access

The DOI matches its Crossref record; 83 of the 84 references it cites were found in a registry or an index.

Abstract

Diffuse large B cell lymphoma (DLBCL), the most common lymphoid malignancy in adults, is a clinically and genetically heterogeneous disease that is further classified into transcriptionally defined activated B cell (ABC) and germinal center B cell (GCB) subtypes. We carried out a comprehensive genetic analysis of 304 primary DLBCLs and identified low-frequency alterations, captured recurrent mutations, somatic copy number alterations, and structural variants, and defined coordinate signatures in patients with available outcome data. We integrated these genetic drivers using consensus clustering and identified five robust DLBCL subsets, including a previously unrecognized group of low-risk ABC-DLBCLs of extrafollicular/marginal zone origin; two distinct subsets of GCB-DLBCLs with different outcomes and targetable alterations; and an ABC/GCB-independent group with biallelic inactivation of TP53, CDKN2A loss, and associated genomic instability. The genetic features of the newly characterized subsets, their mutational signatures, and the temporal ordering of identified alterations provide new insights into DLBCL pathogenesis. The coordinate genetic signatures also predict outcome independent of the clinical International Prognostic Index and suggest new combination treatment strategies. More broadly, our results provide a roadmap for an actionable DLBCL classification.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-018-0016-8

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 83 references

Cited by

See all 1,941

Metadata

Authors
Chapuy, B., Stewart, C., Dunford, A. J., Kim, J., Kamburov, A., Redd, R. A., Lawrence, M. S., Roemer, M. G. M., Li, A. J., Ziepert, M., Staiger, A. M., Wala, J. A., Ducar, M. D., Leshchiner, I., Rheinbay, E., Taylor-Weiner, A., Coughlin, C. A., Hess, J. M., Pedamallu, C. S., Livitz, D., Rosebrock, D., Rosenberg, M., Tracy, A. A., Horn, H., van Hummelen, P., Feldman, A. L., Link, B. K., Novak, A. J., Cerhan, J. R., Habermann, T. M., Siebert, R., Rosenwald, A., Thorner, A. R., Meyerson, M. L., Golub, T. R., Beroukhim, R., Wulf, G. G., Ott, G., Rodig, S. J., Monti, S., Neuberg, D. S., Loeffler, M., Pfreundschuh, M., Trümper, L., Getz, G., & Shipp, M. A.
Affiliations
  • Harvard University (US)
  • Broad Institute (US)
  • Dana-Farber Cancer Institute (US)
  • Boston University (US)
  • Leipzig University (DE)
  • Robert Bosch Hospital (DE)
  • Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology (DE)
  • Mayo Clinic (US)
  • University of Iowa (US)
  • Universität Ulm (DE)
  • University of Würzburg (DE)
  • University of Göttingen (DE)
  • Brigham and Women's Hospital (US)
  • Saarland University (DE)
Corresponding author
  • Getz, Gad
  • Shipp, Margaret A.
Venue
Nature Medicine
Published
2018-04-30
Volume
24
Issue
5
Pages
679-690
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W2801763724
Cited by
1,941
References
84
Citations by year
2026: 159 · 2025: 248 · 2024: 289 · 2023: 292 · 2022: 264 · 2021: 272 · 2020: 219 · 2019: 151 · 2018: 43
FWCI
131.87
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
Funders
  • National Human Genome Research Institute (U54HG003067, T32HG002295)
  • National Cancer Institute (U24CA143845, P50CA097274, U24CA210999, R01CA155010, P01CA163222)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
  • Health Sciences › Medicine › Clinical Neurology › CNS Lymphoma Diagnosis and Treatment
  • Health Sciences › Medicine › Hematology › Chronic Lymphocytic Leukemia Research
Keywords
diffuse large B-cell lymphoma, molecular subtypes, activated B-cell subtype, germinal center B-cell subtype, CDKN2A loss, genomic instability, mutational signatures, somatic copy number alterations, structural variants, consensus clustering, prognostic signature, International Prognostic Index, lymphomagenesis, targeted therapy
MeSH terms
Humans, Mutation, Gene Rearrangement, Lymphoma, Large B-Cell, Diffuse, Treatment Outcome, Genetic Heterogeneity, Genes, Neoplasm, DNA Copy Number Variations, Mutation Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. https://app.cochat.ai/papers/10.1038/s41591-018-0016-8
The paper
Chapuy, B., Stewart, C., Dunford, A. J., Kim, J., Kamburov, A., Redd, R. A., Lawrence, M. S., Roemer, M. G. M., Li, A. J., Ziepert, M., Staiger, A. M., Wala, J. A., Ducar, M. D., Leshchiner, I., Rheinbay, E., Taylor-Weiner, A., Coughlin, C. A., Hess, J. M., Pedamallu, C. S., . . . Shipp, M. A. (2018). Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nature Medicine. https://doi.org/10.1038/s41591-018-0016-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.